Efficacy of epigallocatechin-3-gallate and amla (Emblica officinalis) extract for the treatment of diabetic-uremic patients

Journal of Medicinal Food

Volumn 14, Issue 7-8, 2011, Pages 718-723

  Chen, Tung Sheng ^a   Liou, Show Yih ^b   Wu, Hsi Chin ^c   Tsai, Fuu Jen ^a   Tsai, Chang Hai ^d   Huang, Chih Yang ^a,d   Chang, Yen Lin ^e  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Formosan Blood Purification Foundation   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

( ) epigallocatechin gallate; Amla; atherosclerosis; diabetes; Emblica officinalis; oxidative stress; uremia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; EMBLICA OFFICINALIS EXTRACT; EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GALLATE PLUS EMBLICA OFFICINALIS EXTRACT; GAMMA GLUTAMYLTRANSFERASE; GLOBULIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; PHOSPHATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; URIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DRUG EFFICACY; DRUG SAFETY; EMBLICA OFFICINALIS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LIVER FUNCTION; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; UREMIA; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATECHIN; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; UREMIA;

PHYLLANTHUS EMBLICA;

EID: 79960467541     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.1195     Document Type: Article

References (20)

1. Kormoczi GF, Rosenkranz AR, Zlabinger GJ: Polymorpho-nuclear granulocyte stimulation by cellulose-based hemodialysis membranes. Clin Chem Lab Med 1999;37:351-355. (Pubitemid 29209751)
2. Haag-Weber M, Schollmeyer P, Horl WH: Neutrophil activation during hemodialysis. Adv Exp Med Biol 1989;260:29-37.
3. Koken T, Serteser M, Kahraman A, Gokce C: Oxidative stress markers in hepatitis C infected hemodialysis patients. J Nephrol 2002;15:302-307. (Pubitemid 34830539)
4. Horl WH: Iron therapy for renal anemia: how much needed, how much harmful? Pediatr Nephrol 2007;22:480-489. (Pubitemid 46332324)
5. Sengoelge G, Sunder-Plassmann G, Horl WH: Potential risk for infection and atherosclerosis due to iron therapy. J Ren Nutr 2005;15:105-110. (Pubitemid 40093692)
6. Himmelfarb J: Oxidative stress in hemodialysis. Contrib Nephrol 2008;161:132-137.
7. Noordzij MJ, Lefrandt JD, Smit AJ: Advanced glycation end products in renal failure: an overview. J Ren Care 2008;34:207-212.
8. Meerwaldt R, Zeebregts CT, Navis G, Hillebrands JL, Lefrandt JD, Smit AJ: Accumulation of advanced glycation end products and chronic complication in ESRD treated by dialysis. Am J Kidney Dis 2009;53:138-150.
9. Higdon JV, Frei B: Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003;43:89-143. (Pubitemid 38552312)
10. Frei B, Higdon JV: Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 2003;133:3275S-3284S. (Pubitemid 37222256)
11. Rao TP, Sukaguchi N, Juneja LR, Wada E, Yokozawa T: Amla (Emblica officinalis Gaertn) extracts reduce oxidative stress in strepozocin-induced diabetic rats. J Med Food 2005;8:362-368. (Pubitemid 41502420)
12. Kusirisin W, Scrichairatanokool S, Lertfrakarnnon P, Lailerd N, Suttajit M, Jaikang C, Chaiyasut C: Antioxidant activity, poly-phenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. J Med Chem 2009;5:139-147.
13. Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK: An-tioxidant activity of active tannoid principles of Emblica offici-nalis (amla). Indian J Exp Biol 1999;37:678-680.
14. Othman A, Ismail A, Ghani NA, Adenan I: Antioxidant capacity and phenolic content of cocoa beans. Food Chem 2007;100: 1523-1530. (Pubitemid 44142875)
15. Nakagawa T, Yokozawa T, Kim YA, Kang KS: Activity of wen-pi-tang, and purified constituents of rhei rhizome and glycyrrizae radix against glucose-mediated protein damage. Am J Chin Med 2005;33:817-829. (Pubitemid 41319931)
16. Moshage H, Kok B, Huizenga JR, Jansen PLM: Nitrites and nitrates determination in plasma: a critical evaluation. Clin Chem 1995;41:892-896.
17. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Chem 1979;95: 351-358. (Pubitemid 9194347)
18. Chow HH, Ai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell TA, Yang CS, Hara Y: Phase 1 pharmacokinetic study of tea polyphenol following sing-dose administration of epigalloca-techin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 2001;10:55-58.
19. Chen TS, Liou SY, Chang YL: Supplementation of Emblica officinalis (amla) extract reduces oxidative stress in uremic patients. Am J Chin Med 2009;37:19-25.
20. Tuzcu M, Sahin N, Karatepe M, Cikim G, Kilinc U, Sahin K: Epigallocatechin-3-gallate supplementation can improve antiox-idant status in stressed quail. Br Poult Sci 2008;49:643-648.